Session Overview

The blood-brain barrier (BBB) is a selectively permeable barrier which separates brain extracellular fluid from circulating blood. It protects the brain from unwanted substances by controlling entry of molecules into the brain.

It is difficult to do large-scale drug screening in vivo to check if new molecules can cross the BBB, and hence there is a need for tissue models. Current tissue models, however, are often unrealistic and difficult to reproduce.

This session welcomes speakers looking to address this need with their research.

Session Chair: Dr Sikha Saha

Lecturer and Director of MCRC Impact and Innovation

University of Leeds

Investigations of novel targets, metabolic profiling, drug delivery, toxicity testing and development of diagnostic tools for cardiovascular and cerebrovascular diseases using novel in vitro organ flow system and in vivo mammalian models

Keynote Speaker: Professor Joan Abbott

PROFESSOR JOAN ABBOTT

EMIRITUS PROFESSOR OF NEUROSCIENCE

KINGS COLLEGE LONDON

 

VIEW PROFILE

The Presenters

 

Dr Virginia Pensabene

University Academic Fellow

University of Leeds

To be confirmed

Call for Papers





 

REGISTER NOW